Tuberculosis Blood Testing Explained

What a TB Blood Test Measures

A tuberculosis blood test, sometimes called an interferon gamma release assay, measures how the immune system responds to proteins found in TB bacteria. A small blood sample is mixed with these proteins, and the test detects whether certain immune cells react. The result reflects prior exposure to TB bacteria, whether or not the person feels ill.

Because it uses a blood sample, the test is completed in a single visit. The older skin test requires two visits, one to place the test and one to read the result. Many clinics and programs now use the blood test because it is convenient and does not require a follow-up reading.

Blood Test versus Skin Test

The skin test and the blood test both detect immune sensitization to TB, but they differ in practical ways. The skin test requires a return visit, and its reading can be affected by the reader's technique and by prior BCG vaccination. The blood test avoids those issues and is not affected by BCG vaccination, which is useful for people who were vaccinated in countries where BCG is routine.

Neither test can tell latent TB from active TB on its own. That distinction requires symptoms, imaging, and sometimes samples from the lungs. A positive result is therefore the start of an evaluation, not the end of it.

How to Order and Where to Get Tested

TB blood testing can be ordered through direct-access services in most states and is also offered by many occupational health programs. A licensed clinician reviews the request, and you visit a CLIA-certified lab for a blood draw. Results usually appear in a secure portal within a few business days.

Bring a photo ID and the order details. If the test is for school, work, or travel, check which test the program accepts, since requirements vary. Tell the lab about any medicines that affect the immune system, because these can influence the result.

How Much Does TB Testing Cost?

Self-pay TB blood testing is moderately priced. A single test is affordable, and some panels combine TB screening with other tests. Because there is no second visit for a reading, the total cost can be lower than the skin test when you factor in time.

Insurance may cover testing a clinician orders when there is a medical reason. If you pay yourself, ask what is included. Community clinics and public health programs sometimes provide low-cost TB screening, so it is worth asking if cost is a factor.

Reading Your Results

The test is usually reported as positive, negative, or indeterminate. A negative result means the immune response was not detected. A positive result means the immune system has been sensitized to TB proteins, which can reflect latent infection. An indeterminate result means the test could not give a clear answer, and repeat testing may be suggested.

A positive result should be evaluated by a clinician. Latent TB is a condition in which the bacteria are present but not causing illness, and it can be managed. Active TB is different and requires prompt medical care.

When to Talk With a Clinician

A positive or indeterminate result needs professional follow-up. A licensed clinician can assess symptoms, order imaging or other tests, and explain what the result means in your situation. Do not assume a positive test means active illness, and do not ignore it either.

Use direct testing for screening and documentation, and rely on a clinician for evaluation and care. That keeps the process accurate and safe.

IGRA vs Skin Testing

Tuberculosis infection can be detected with a blood test called an interferon-gamma release assay, or with a skin test. The blood test requires a single visit and is not affected by prior BCG vaccination, which is an advantage for people who received that vaccine. The skin test requires a return visit to read the result.

Both approaches show whether the immune system has responded to TB proteins, but neither distinguishes latent from active disease. If a result is positive, imaging and other evaluation determine whether the infection is latent or active. A clinician directs that follow-up.

If you have symptoms such as a persistent cough, fever, or weight loss, tell a clinician promptly rather than relying on a screening test, because active disease needs separate evaluation.